Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-Fluorocholine PET/CT Diagnostic Accuracy Basket Trial
NCT04150458Phase 3Enrolling by invitation
- Sponsor
- Jewish General Hospital
- Start
- Nov 2022
- Primary completion
- Jan 2030
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial, sponsored by Jewish General Hospital. Primary endpoint: Diagnostic accuracy of Fluorocholine PET/CT at 1 day. Started Nov 2022; status: enrolling by invitation.
Beyond the preview
Go deeper on NCT04150458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04150458.